0001171843-21-007383.txt : 20211102 0001171843-21-007383.hdr.sgml : 20211102 20211102083022 ACCESSION NUMBER: 0001171843-21-007383 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20211102 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Atreca, Inc. CENTRAL INDEX KEY: 0001532346 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273723255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38935 FILM NUMBER: 211369383 BUSINESS ADDRESS: STREET 1: 835 INDUSTRIAL ROAD, STREET 2: SUITE 400 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-595-2595 MAIL ADDRESS: STREET 1: 835 INDUSTRIAL ROAD, STREET 2: SUITE 400 CITY: SAN CARLOS STATE: CA ZIP: 94070 8-K 1 f8k_110121.htm FORM 8-K Form 8-K
0001532346 False 0001532346 2021-11-02 2021-11-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  November 2, 2021

_______________________________

Atreca, Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware001-3893527-3723255
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

835 Industrial Rd., Suite 400

San Carlos, California 94070

(Address of Principal Executive Offices) (Zip Code)

(650) 595-2595

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per shareBCELThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 
Item 2.02. Results of Operations and Financial Condition.

On November 2, 2021, Atreca, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended September 30, 2021 and its recent corporate developments. A copy of such press release is furnished hereto as Exhibit 99.1.

The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference under the Securities Act of 1933, as amended, or into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, except as expressly set forth by reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number Exhibit Description
   
99.1 Press Release titled “Atreca Reports Third Quarter 2021 Financial Results and Recent Corporate Developments,” dated November 2, 2021, furnished herewith
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 Atreca, Inc.
   
  
Date: November 2, 2021By: /s/ Herbert Cross        
  Herbert Cross
  Chief Financial Officer
  

 

 EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

Atreca Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

SAN CARLOS, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced financial results for the third quarter ended September 30, 2021, and provided an overview of recent developments.

"In the third quarter, we continued to advance our lead program, ATRC-101, following the release of initial summary data from the dose escalation portion of the Phase 1b trial, which supports the further evaluation of ATRC-101 in multiple solid tumor types,” said John Orwin, Chief Executive Officer. “We plan to share additional monotherapy data and initial combination data with pembrolizumab in 2022, and are in a strong position to advance our pipeline with cash runway through mid-2023.”

“Our earlier-stage programs are progressing well, highlighted by our recently announced licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501, a novel monoclonal antibody entering preclinical development for the prevention of malaria,” said Tito Serafini, Ph.D., Chief Strategy Officer. “We look forward to sharing more information on our EphA2 program and other pipeline assets at an R&D day early next year.”

Recent Developments and Highlights

  • Atreca announced a licensing agreement with the Bill & Melinda Gates Medical Research Institute (“Gates MRI”) for development and commercialization of MAM01/ATRC-501, a monoclonal antibody for malaria prophylaxis. Under the agreement, Gates MRI will lead the development of MAM01/ATRC-501 and receive commercial rights in GAVI-eligible countries located in malaria-endemic regions of the world, while Atreca will retain commercial rights in the U.S., Europe and parts of Asia. Potential product development opportunities for Atreca include developing MAM01/ATRC-501 for prevention of malaria for those traveling to regions where the infection may be circulating.
  • Enrollment in the monotherapy portion of the Phase 1b trial of ATRC-101 is ongoing at 30 mg/kg and Atreca plans to report additional monotherapy data in mid-2022.
  • Enrollment has commenced in a Phase 1b combination cohort evaluating ATRC-101 with pembrolizumab. Another combination cohort with pegylated liposomal doxorubicin (“PLD”) is expected to begin enrolling patients following completion of ongoing monotherapy cohorts, including those following a Q2W dosing schedule which better aligns with the standard PLD regimen. Atreca plans to report additional monotherapy data in mid-2022 and pembrolizumab combination data in 3Q22.

Third Quarter 2021 Financial Results

  • As of September 30, 2021, cash and cash equivalents and short-term investments totaled $152.9 million.

  • Research and development expenses for the three months ended September 30, 2021 were $18.7 million, including non-cash share-based compensation expense of $1.9 million.

  • General and administrative expenses for the three months ended September 30, 2021 were $8.8 million, including non-cash share-based compensation expense of $1.9 million.

  • Atreca reported a net loss of $27.4 million, or basic and diluted net loss per share attributable to common stockholders of $0.74, for the three months ended September 30, 2021.

About Atreca, Inc.

Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca's platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basis for first-in-class therapeutic candidates, such as our lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients. For more information on Atreca, please visit www.atreca.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions and typically are identified by use of terms such as “will,” “expect,” “potential,” “plan,” “continue,” and similar words, although some forward-looking statements are expressed differently. These statements include those related to our strategy and future plans, including statements regarding the development of ATRC-101 and our preclinical, clinical and regulatory plans and the timing thereof, the availability and timing of ATRC-101 monotherapy and initial combination data with pembrolizumab and enrollment in, and timing of, a combination cohort with pegylated liposomal doxorubicin, our cash runway and the timing thereof, the development of MAM01/ATRC-501, its potential for prevention of malaria, our potential product development opportunities to develop MAM01/ATRC-501 for prevention of malaria for those traveling to regions where the infection may be circulating, and the status of our earlier-stage programs and our plan to share information regarding our EphA2 program and other pipeline assets and the timing thereof. Our actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties related to the initiation, timing, progress and results of our research and development programs, preclinical studies, clinical trials, regulatory submissions, and other matters that are described in our filings with the Securities and Exchange Commission (SEC) and available on the SEC’s website at www.sec.gov, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release, and we undertake no obligation to update any forward-looking statement in this press release, except as required by law.


Atreca, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)

     
  September 30, December 31,
   2021   2020 
  (unaudited)  
ASSETS    
     
Current Assets
Cash and cash equivalents $113,189  $60,789 
Investments  39,697   179,296 
Prepaid expenses and other current assets  9,180   9,037 
Total current assets  162,066   249,122 
Property and equipment, net  44,291   19,831 
Long-term investments  10,824   - 
Deposits and other  3,080   3,111 
Total assets $220,261  $272,064 
     
LIABILITIES AND STOCKHOLDERS’ EQUITY
     
Current Liabilities
Accounts payable $5,238  $5,216 
Accrued expenses  9,286   10,302 
Other current liabilities  1,631   1,900 
Total current liabilities  16,155   17,418 
Capital lease obligations, net of current portion  -   4 
Deferred rent  28,677   12,585 
Total liabilities  44,832   30,007 
     
     
Stockholders’ equity
Common stock  4   4 
Additional paid-in capital  505,680   492,436 
Accumulated other comprehensive income (loss)  (6)  58 
Accumulated deficit  (330,249)  (250,441)
Total stockholders’ equity  175,429   242,057 
Total liabilities and stockholders’ equity $220,261  $272,064 


Atreca, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
(unaudited)

($ amounts in 000's, except per share amounts)        
          
   Three Months Ended Nine Months Ended
   September 30, September 30,
    2021   2020   2021   2020 
          
Expenses        
 Research and development $18,721  $16,808  $56,145  $45,198 
 General and administrative  8,796   6,614   24,648   20,195 
 Total expenses  27,517   23,422   80,793   65,393 
Interest and other income (expense)        
 Other income  158   353   851   987 
 Interest income  36   142   183   1,082 
 Interest expense  (1)  (1)  (3)  (3)
 Loss on disposal of property and equipment  (34)  -   (45)  - 
Loss before Income tax expense  (27,358)  (22,928)  (79,807)  (63,327)
Income tax expense  -   (1)  (1)  (1)
Net loss $(27,358) $(22,929) $(79,808) $(63,328)
Net loss per share, basic and diluted $(0.74) $(0.66) $(2.16) $(2.09)
Weighted-average shares used in computing        
net loss per share, basic and diluted  36,918,255   34,723,888   36,884,665   30,313,047 

Contacts

Atreca, Inc.
Herb Cross
Chief Financial Officer
info@atreca.com

Investors:
Alex Gray, 650-779-9251
agray@atreca.com

Media:
Rachel Ford Hutman, 301-801-5540
Rachel@fordhutmanmedia.com

Source: Atreca, Inc.

 EX-101.SCH 3 gnw-20190101.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gnw-20190101_def.xml XBRL DEFINITION FILE EX-101.LAB 5 gnw-20190101_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 gnw-20190101_pre.xml XBRL PRESENTATION FILE XML 7 f8k_110121_htm.xml IDEA: XBRL DOCUMENT 0001532346 2021-11-02 2021-11-02 iso4217:USD shares iso4217:USD shares 0001532346 false 8-K 2021-11-02 Atreca, Inc. DE 001-38935 27-3723255 835 Industrial Rd., Suite 400 San Carlos CA 94070 650 595-2595 false false false false Class A Common Stock, $0.0001 par value per share BCEL NASDAQ true false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover
Nov. 02, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 02, 2021
Entity File Number 001-38935
Entity Registrant Name Atreca, Inc.
Entity Central Index Key 0001532346
Entity Tax Identification Number 27-3723255
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 835 Industrial Rd., Suite 400
Entity Address, City or Town San Carlos
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94070
City Area Code 650
Local Phone Number 595-2595
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, $0.0001 par value per share
Trading Symbol BCEL
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://globenewswire.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_110121.htm exh_991.htm gnw-20190101.xsd gnw-20190101_def.xml gnw-20190101_lab.xml gnw-20190101_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f8k_110121.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "gnw-20190101_def.xml" ] }, "inline": { "local": [ "f8k_110121.htm" ] }, "labelLink": { "local": [ "gnw-20190101_lab.xml" ] }, "presentationLink": { "local": [ "gnw-20190101_pre.xml" ] }, "schema": { "local": [ "gnw-20190101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "gnw", "nsuri": "http://globenewswire.com/20190101", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_110121.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://globenewswire.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_110121.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001171843-21-007383-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-21-007383-xbrl.zip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end